The Epidemiological Boehringer Ingelheim Employee Study – Part I: Impact of Overweight and Obesity on Cardiometabolic Risk

9. Juli 2013

The BI Employee study is a working population cohort. Employees (inclusion criteria: ≥38 years; employed for at least 2 years; no exclusion criteria) of BI Pharma GmbH & Co. KG were invited by the medical corporate department to participate in the prevention and health care programme “FIT IM LEBEN-FIT IM JOB”. This program is still ongoing…

https://www.hindawi.com/journals/jobe/2013/159123/

Autoren: Kerstin Kempf, Stephan Martin, Carmen Döhring, Klaus Dugi, Carolin Wolfram von Wolmar, Burkhard Haastert, and Michael Schneider

Prof. Dr. Martin

Chefarzt für Diabetologie und Direktor des Westdeutschen Diabetes- und Gesundheitszentrum (WDGZ) in Düsseldorf